US pharma giant Merck & Co (NYSE: MRK) has announced financial results for the fourth quarter and full year of 2025. Merck’s ...
US pharma giant Pfizer today announced positive top-line results from the Phase IIb VESPER-3 study investigating monthly ...
Pfizer (NYSE: PFE) posted fourth-quarter 2025 revenue of about $18 billion, down 1% from the year-ago quarter, and adjusted ...
The UK and Japan have announced a major package of science and technology collaborations, it has been announced.
Danish drugmaker Novo Nordisk has announced headline results from REIMAGINE 2, a Phase III study from the global REIMAGINE clinical trial program.
Norwegian cell therapy developer Zelluna (OSE: ZLNA) has promoted Emilie Gauthy to chief technology officer, effective immediately. Ms Gauthy joined the company in 2022 and has led manufacturing and ...
Cambridge, USA-based precision medicines specialist Relay Therapeutics today announced that the US Food and Drug ...
US clinical-stage biotech Sagimet Biosciences' shares rose 10% to $6.23 after it announced that China-based partner Ascletis ...
South Korean vaccine specialist SK bioscience has in-licensed a clinical-stage respiratory syncytial virus (RSV) preventive ...
Cambridge, UK-based biotech Bicycle Therapeutics, which is pioneering a new and differentiated class of therapeutics based on ...
A privately held ophthalmic company headquartered in Southern California (Aliso Viejo). The company’s development work is ...
A Paris-based biotech/deeptech company developing rapid microbiology testing for industrial quality control. Its deployment ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results